About: Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1984 (uk) article scientifique publié en 1984 (fr) im Januar 1984 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q59315510-2C17195D-79AA-44B1-81AB-22D54CAFC3CC
publication date	1984-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q59315510-D02F00F0-6408-4E15-B9DE-6A474F3B4A42
exact match	https://scigraph.springernature.com/pub.10.1007/bf00254604
cites work	wds:Q59315510-05F33747-CE0C-49F2-B36D-2AD63BB747E2 wds:Q59315510-27389C9E-3A19-47D2-95A3-658CA8334208 wds:Q59315510-3C3A8A92-76AD-4E62-8E06-446CC81741C5 wds:Q59315510-50292BC9-411A-43BD-85FB-8B79EB201524 wds:Q59315510-5807EAF5-6A5F-47E2-87C3-F694B81FD45A wds:Q59315510-79BE7765-6118-47F4-AD6E-E42B9056960E wds:Q59315510-909B60D5-2FFE-4E7D-8DEF-0E4BDD93EE19 wds:Q59315510-94E5B7B9-E6B2-416E-AA21-FA329A9F7D02 wds:Q59315510-9DC25C1F-7421-409F-AAF5-49131FDDFD94 wds:Q59315510-A0D0D61C-C210-42C0-9F2C-D67684772FEC wds:Q59315510-C11D6CFD-E6C4-47D0-BACC-653EBF8A2DE0 wds:Q59315510-C94B5655-EF92-49D9-9199-D485A3ECCE86 wds:Q59315510-E491E269-AE49-42F1-9722-CEDA132E381E wds:Q59315510-E4F7897C-534F-4699-A783-DFF9FDE3297A wds:Q59315510-F3781FEA-182B-4B7C-B3DC-A6580E2925F6
cites work	Failure of remission induction in acute myelocytic leukemia Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia Treatment of acute myeloid leukaemia with a triple cytotoxic regime: dat Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography Effects of prior therapy on plasma levels of adriamycin during subsequent therapy Plasma and urinary levels of adriamycin in man Treatment failure in AML. Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay Prevention of infection and bleeding in leukemic patients receiving intensive remission maintenance therapy Growth of human acute myeloblastic leukemic (AML) cells in vitro Remission induction in acute nonlymphocytic leukemia: comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin Pharmacokinetics of adriamycin (NSC-123127) in patients with sarcomas
author name string	wds:Q59315510-455F38E4-C093-4929-82C5-DD331BB4B727 wds:Q59315510-77DAC4A3-B272-4342-830C-ED4BF1F23CAA wds:Q59315510-7AC7D845-0DDC-435C-9B6C-D3D85149F85C wds:Q59315510-822B67E9-B8C4-467A-AD86-D3E7E37082BC wds:Q59315510-8A4056D8-0330-469C-BD84-738A71567003 wds:Q59315510-8FF57FDD-94B3-4CD9-9576-2FB542BA8302 wds:Q59315510-97987FE7-5B06-458B-83BE-31E71BA53B51 wds:Q59315510-9DECA9C4-FD78-4A5A-8922-76F5A3C7B9B0 wds:Q59315510-E24D9E9D-E864-4059-AB41-0DA077E83572 wds:Q59315510-ED631E4E-F4A7-4415-8970-00BF8090CBDA
author name string	R Vogler J Epstein T Gessner H D Preisler N Azarnia W Bolanowska A P Early L Winton P Chervenik P D'Arrigo
rdfs:label	Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia (en) Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia (nl)
skos:prefLabel	Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia (en) Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia (nl)
name	Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia (en) Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia (nl)
title	wds:Q59315510-94ED94D5-B61B-4CF7-A5FE-78EF432D4BDD
title	Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia (en)
page(s)	wds:Q59315510-86C6528B-283F-4CC9-961B-44BED8C3570F
page(s)	125-130
instance of	wds:Q59315510-6F3BDC98-225E-4766-8D7E-16C233E59B6D
instance of	scholarly article
main subject	wds:Q59315510-2C690F0A-1337-4DAD-815A-7221BDE10C9F wds:Q59315510-BE0B8AE5-6D63-4EC5-A60F-CE56EA56413B wds:Q59315510-FE0B74B2-B1CB-4FEA-A4BB-CCB57A1A7A4B
main subject	wd:Q18936 leukemia toxicology
PubMed ID	wds:Q59315510-F4AAB675-3C97-4549-B322-09611E3E2EA5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6697426
PubMed ID	6697426
published in	wds:Q59315510-C6D69860-035E-4D1E-B847-9CF6118EB65E
published in	Cancer Chemotherapy and Pharmacology
issue	wds:Q59315510-8341926B-3B84-4D54-B64E-8ED084897443
volume	wds:Q59315510-9E29B964-C900-4027-82E1-30FBE08721F4
issue	2
volume	12
DOI	wds:Q59315510-6DEE1CBA-C262-47F8-9B3C-C8E334C82824
DOI	http://dx.doi.org/10.1007/BF00254604
DOI	10.1007/BF00254604
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59315510
is cites work of	Pharmacokinetics of doxorubicin in man: dose and schedule dependence Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme A phase II study of high dose epirubicin in unresectable non small cell lung cancer In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software